about
Pattern Recognition Receptors in Cancer Progression and MetastasisEmerging role of Toll-like receptor 4 in hepatocellular carcinomaInterleukin-1 loop model for pathogenesis of Langerhans cell histiocytosisInhibition of Myeloid Differentiation Factor 88 Reduces Human and Mouse T-Cell Interleukin-17 and IFNγ Production and Ameliorates Experimental Autoimmune Encephalomyelitis Induced in MiceFormal modeling and analysis of the MAL-associated biological regulatory network: insight into cerebral malaria.Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease.Blockade of the N-Methyl-D-Aspartate Glutamate Receptor Ameliorates Lipopolysaccharide-Induced Renal Insufficiency.The first whole genome and transcriptome of the cinereous vulture reveals adaptation in the gastric and immune defense systems and possible convergent evolution between the Old and New World vulturesThe Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal MucositisVaccinia Virus Immunomodulator A46: A Lipid and Protein-Binding Scaffold for Sequestering Host TIR-Domain ProteinsMicroRNA367 negatively regulates the inflammatory response of microglia by targeting IRAK4 in intracerebral hemorrhage.Encephalomyocarditis Virus 3C Protease Relieves TRAF Family Member-associated NF-κB Activator (TANK) Inhibitory Effect on TRAF6-mediated NF-κB Signaling through Cleavage of TANK.Suppression of TLR signaling by targeting TIR domain-containing proteinsShould a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancersLipoteichoic acid isolated from Lactobacillus plantarum suppresses LPS-mediated atherosclerotic plaque inflammation.Deficiency of the myeloid differentiation primary response molecule MyD88 leads to an early and rapid development of Helicobacter-induced gastric malignancy.Innate immune response precedes Mycobacterium leprae-induced reprogramming of adult Schwann cells.Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.Challenges in understanding the immunopathogenesis of Cryptosporidium infections in humans.Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells.Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling.NUR77 exerts a protective effect against inflammatory bowel disease by negatively regulating the TRAF6/TLR-IL-1R signalling axis.Follistatin alleviates synovitis and articular cartilage degeneration induced by carrageenanMicroRNA-93 inhibits inflammatory responses and cell apoptosis after cerebral ischemia reperfusion by targeting interleukin-1 receptor-associated kinase 4.A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases.Stressor-induced increase in microbicidal activity of splenic macrophages is dependent upon peroxynitrite production.TLR4-mediated inflammation is a key pathogenic event leading to kidney damage and fibrosis in cyclosporine nephrotoxicity.Role of TLR4 as a prognostic factor for survival in various cancers: a meta-analysis.Modular bioinformatics analysis demonstrates that a Toll‑like receptor signaling pathway is involved in the regulation of macrophage polarizationMerkel cell polyomavirus and Langerhans cell neoplasm
P2860
Q26798034-E5E6D617-1A99-4EF2-8C50-C42E943E4065Q26824613-410155F5-12FD-493B-808F-0919EBAA4CCBQ28083455-A7C96260-70E3-4B6D-8274-263FE5C70448Q33734635-490ECA3C-7BA2-4873-B81B-B79C228F1C44Q34221466-0429A42E-A104-4692-A27F-86794B409C63Q34385900-10A7FB10-8849-42ED-A49E-BAC7D2F69307Q35680398-3BF62FB1-AE2F-4136-84E5-D3C250F95842Q35815123-C87867BC-4D4D-45D2-BB47-DE480041CB5DQ36126947-B216EA33-BDEF-42A8-A1F4-E4A661FE05E7Q36223863-1FC753CD-EB6B-4ED9-BE83-BD1501BD3AC2Q36266981-49647230-EA32-4534-AEC4-0230F062ACD4Q36282871-B69EF47C-C3F2-4D0B-9EF9-3EC90FC0F036Q36676056-6CD8819A-BD18-4D67-8AB4-03DEE10B5BADQ37291780-DE66FC25-C004-45DA-A7DB-C836A439759CQ37462325-12C04617-91FA-4082-8D65-91E3EC6D05E3Q37548248-8A6B59C7-E008-4821-A74B-799B43A503B1Q37577074-B23B8608-A757-476A-979A-97D8D5557FABQ37800819-4B2D27A8-FF0D-48F9-987D-C1C4DEB0BF23Q37864135-EDD2DE99-DAA6-45FD-91D7-94B7E0DF2AEDQ39098027-741372DB-6F4B-4C55-A0FA-5893A926060AQ39688016-DD9FD664-FD2F-4D3E-8DD1-85BF2574068EQ40325258-9C7B19C6-E3BC-48D6-BD95-0063788FA6B3Q41601141-0EB5EB12-5072-45DB-8216-466568BAF321Q41623592-1E8ACBEC-10CE-46A6-B82A-5BB875F05BDAQ41787535-1E52B799-7495-4A67-A550-96D78BE3F499Q42153484-A1E973EA-E8C4-4407-9313-817DAC411DB3Q51538354-E7650025-E86C-4497-8AFF-66DDE52639FDQ52645842-CAF5BDF2-5126-42D3-8DA9-8B1BD65FE3B9Q57157340-830EDD1B-EB70-40CB-8C1A-63522012EA23Q58724203-3311A4B5-99FA-4A16-BE68-DDB33A2B7215
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting TLR/IL-1R signalling in human diseases.
@en
Targeting TLR/IL-1R signalling in human diseases.
@nl
type
label
Targeting TLR/IL-1R signalling in human diseases.
@en
Targeting TLR/IL-1R signalling in human diseases.
@nl
prefLabel
Targeting TLR/IL-1R signalling in human diseases.
@en
Targeting TLR/IL-1R signalling in human diseases.
@nl
P2860
P921
P356
P1476
Targeting TLR/IL-1R signalling in human diseases
@en
P2093
Maria Loiarro
Vito Ruggiero
P2860
P304
P356
10.1155/2010/674363
P577
2010-04-08T00:00:00Z